drugset / Trial / NCT06789185
Effects of Esketamine at Subanesthetic Dose on Emergence Delirium in Preschool Children Undergoing Ambulatory Laparoscopic Surgery
RandomizedParallel-groupQuadruple-blindPrevention
Summary
Emergence delirium (ED) is a manifestation of acute postoperative brain dysfunction that occurs with a relatively high frequency after pediatric anesthesia. The incidence varies depending on the diagnostic criteria used and the combination of administered anesthetic drugs. The goal of this clinical trial is to investigate whether a subanesthetic dose of esketamine can reduce incidence of ED.
Timeline
- Start
- 2025-02-07
- Primary completion
- 2025-05-16
- Completion
- 2025-05-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esketamine | Other / unclassified | 0.1 mg/kg | Intravenous |
| Subject | Esketamine | Other / unclassified | 0.2 mg/kg | Intravenous |
Indications
No indication recorded.